Date of Transaction: 31 December 2025

Announcement Date: 2 January 2026

Company: IHH Healthcare Berhad

Stock Name: IHH

Designation: Non-Executive Director, Mr. Mehmet Ali Aydinlar

Key Transaction Details

• Type of Transaction: Disposal of Ordinary Shares
• Number of Shares Disposed: 1,000,000 ordinary shares
• Percentage of Total Issued Shares Disposed: 0.011%
• Consideration Price: MYR 8.590 per share

Post-Transaction Shareholdings of Mr. Mehmet Ali Aydinlar

The following details outline Mr. Mehmet Ali Aydinlar’s direct and indirect interests in IHH Healthcare Berhad after the disposal:

• Direct Interests:
  • Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
  • Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for Mehmet Ali Aydinlar: 948,000 ordinary shares
• Indirect Interests:
  • Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
  • Raffles Nominees (Pte) Limited: 207,620,000 ordinary shares
  • Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi: 297,601,573 ordinary shares

Investor Insights & Price Sensitivity

• Director Selling Activity: The disposal of shares by a non-executive director, especially in such a sizable amount (1,000,000 shares at MYR 8.590 each), may be interpreted as significant by the market. Large director transactions often attract investor attention and can influence share price sentiment.
• Timing of Disposal: The disposal was made outside the closed period, suggesting there is no restriction due to material undisclosed information. However, investors should monitor for any subsequent insider selling or buying activity which may indicate changing sentiment among key shareholders.
• Remaining Shareholding: Despite this disposal, Mr. Aydinlar retains substantial direct and indirect holdings in the company, including major stakes held through nominee accounts and related entities. This suggests continued alignment with the company’s long-term prospects.
• Price Impact: The sale price (MYR 8.590) can provide a reference point for recent trading valuation. If the transaction was conducted at a premium or discount to market price, it may signal Mr. Aydinlar’s view on the company’s valuation.

What Shareholders Should Know

• Potential Share Price Movement: Such a transaction by a major shareholder and director could prompt increased trading activity or volatility as investors assess the reasons behind the sale and its implications.
• Continued Substantial Shareholding: The director’s remaining holdings remain significant, mitigating concerns of a complete exit but still raising questions about the rationale for the partial disposal.
• No Indication of Company-Specific Negative News: The transaction was reported as occurring outside the closed period, with no mention of material adverse information.

Conclusion

This reported disposal of shares by Mr. Mehmet Ali Aydinlar, a non-executive director, is noteworthy. Investors should view this as potentially price sensitive, given the size of the transaction and the director’s strategic position in the company. Shareholders are encouraged to monitor further disclosures and trading activity in IHH Healthcare Berhad for additional context.

Disclaimer: This article is provided for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisors before making any investment decisions based on director dealings or other company disclosures.

View IHH Historical chart here